Andrew Huang is a dedicated researcher with a focus on biotechnology, cancer therapeutics, and nanomaterials. His recent work has involved developing chimeric polypeptides for targeted anti-cancer chemotherapy, aiming to improve drug delivery and reduce toxic side effects. By engineering self-assembling nanoparticles, Andrew's research explores innovative methods for controlled drug release, enhancing the precision and effectiveness of cancer treatment. His contributions have advanced understanding in the field of targeted therapeutics, combining expertise in molecular engineering and drug design. As a mentor, Andrew shares his skills in biochemistry, nanotechnology, and experimental design, guiding students to push boundaries in cancer research and therapeutic development.